Navigation Links
Thoracic endografts used successfully to remove tumors invading the aorta
Date:5/8/2013

Minneapolis, MN, May 8, 2013 Tumors have the potential to grow locally and invade neighboring organs. Some chest tumors may invade one of the great vessels of the body, the aorta. Surgical removal of these tumors is very challenging and necessitates the support of a heart-lung machine. Therefore there is an increased risk of complication and death. In a small series of patients, placing a stent within the aorta facilitated the subsequent removal of tumor and eliminated the need for heart-lung bypass. A report of these results is presented by Stphane Collaud, MD, MSc, at the Emerging Technology and Techniques Forum of the 93rd AATS Annual Meeting in Minneapolis on May 8, 2013.

Endovascular grafts are inserted into blood vessels in the groin, and then threaded through the vasculature until they reach the aorta, where they prop up the vascular wall and keep the lumen open. Endovascular thoracic stent-grafts are indicated for use in aortic aneurysms, dissections, traumatic injuries, and rupture of the aorta. However, worldwide, these vessel prostheses have only been used anecdotally for helping in the removal of tumors invading the aorta.

In this retrospective single-center study at the University of Toronto, five patients with tumors infiltrating the aorta received an aortic endograft 1-9 days prior to tumor resection. Three patients had non-small cell lung carcinomas and two had sarcomas. The proximal end of the stent-graft was placed in the aortic arch or descending aorta. The tumor was resected en bloc (as one unit) in all patients and was combined with resection of the chest wall and spine in four of five patients.

"We describe the off-label use of endografts in the oncological setting. We suggest that the indication for thoracic aortic endografts could be extended to specific oncological cases," says Dr. Collaud, a thoracic surgeon affiliated with Toronto General Hospital, University Health Network, and the University of Toronto. "This minimally invasive approach allowed safer removal of complex tumors invading the aorta without the need for a heart-lung machine."

After 9 to 62 months, all patients had survived and remained free of disease. There were no endograft-related complications.


'/>"/>

Contact: Nicole Baritot
press@aats.org
978-299-4520
American Association for Thoracic Surgery
Source:Eurekalert

Related medicine news :

1. Video-assisted thoracic surgery valuable tool in lung cancer screening
2. General thoracic surgeons emerge as leading providers of complex, noncardiac thoracic surgery
3. American Thoracic Society relaunches Annals of the American Thoracic Society
4. American Thoracic Society to host free patient events during international conference in May
5. Sheldon Jordan MD, FAAN Releases New Book on Thoracic Outlet Syndrome (TOS) for the Medical Community through Springer Publishing
6. CNIO scientists successfully test the first gene therapy against aging-associated decline
7. Ben-Gurion U. researchers successfully test solar desalination system for arid land agriculture
8. New drug successfully halts fibrosis in animal model of liver disease
9. Barrow researchers successfully destroy brain tumor cells
10. Muscular Contusions Are Now Being Treated Successfully by Dr. Farshchian Using Cell Therapy
11. Dr. Farshchian: Muscular Contusions are Now Being Treated Successfully at The Center for Regenerative Medicine in Miami
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/7/2016)... (PRWEB) , ... December 07, 2016 , ... The medical ... holidays and winter seasons. One major study analyzing heart attacks among 138,602 people ... August of a given year. We would all agree of course–no time of year ...
(Date:12/7/2016)... ... December 07, 2016 , ... Gensuite is honored to be ... Best New Product Launch category. Gensuite’s entry on their EZ Scan feature detailed ... Events & Training Group is a professional event and training provider based in ...
(Date:12/7/2016)... ... December 07, 2016 , ... Maureen McLaughlin, LA.c., a certified ... Associates of Connecticut (RMACT). McLaughlin brings nearly 20 years of experience with fertility ... patients realize their family building goals. Acupuncture helps fertility patients by ...
(Date:12/7/2016)... ... December 07, 2016 , ... “Tomorrow Trump Goes To Washington”: a brief ... the presidency and to America. “Tomorrow Trump Goes To Washington” is the creation of ... can for this country. , Nancy attributes her patriotic nature to her WWII veteran ...
(Date:12/7/2016)... (PRWEB) , ... December 07, 2016 , ... “Fred Rides ... sweet Christmas Day that follows. , “Fred Rides a Train” is the creation ... and short stories since her teen years in Michigan. The "Fred, the Dog" series ...
Breaking Medicine News(10 mins):
(Date:12/6/2016)... SAN DIEGO , Dec. 6, 2016 /PRNewswire/ ... leading RNA medicines company, announced today that it ... to develop RNA-based therapeutics for the treatment of ... Arcturus, wholly-owned therapeutic delivery platform LUNAR™ and UNA ... "Given Takeda,s long-standing commitment to and ...
(Date:12/6/2016)... JOLLA, Calif. , Dec. 6, 2016 /PRNewswire/ ... a biopharmaceutical company leading the discovery and development ... new drug development candidates at its R&D day, ... The first candidate, RGLS5040, is an anti-miR targeting ... The second candidate, RGLS4326, is an anti-miR targeting ...
(Date:12/6/2016)... new study released today by the Alliance for ... Drug Pricing Program will continue to expand at an unprecedented ... exceed $23 billion in total purchases at the 340B price. ... Part B drug reimbursement purchases over the next five years. ... of data on total drug purchases through 340B from 2005 ...
Breaking Medicine Technology: